+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Murine Leukemia Virus (MLV)-based Coronavirus Spike-pseudotyped Particle Production and Infection

Murine Leukemia Virus (MLV)-based Coronavirus Spike-pseudotyped Particle Production and Infection


Viral pseudotyped particles (pp) are enveloped virus particles, typically derived from retroviruses or rhabdoviruses, that harbor heterologous envelope glycoproteins on their surface and a genome lacking essential genes. These synthetic viral particles are safer surrogates of native viruses and acquire the tropism and host entry pathway characteristics governed by the heterologous envelope glycoprotein used. They have proven to be very useful tools used in research with many applications, such as enabling the study of entry pathways of enveloped viruses and to generate effective gene-delivery vectors. The basis for their generation lies in the capacity of some viruses, such as murine leukemia virus (MLV), to incorporate envelope glycoproteins of other viruses into a pseudotyped virus particle. These can be engineered to contain reporter genes such as luciferase, enabling quantification of virus entry events upon pseudotyped particle infection with susceptible cells. Here, we detail a protocol enabling generation of MLV-based pseudotyped particles, using the Middle East respiratory syndrome coronavirus (MERS-CoV) spike (S) as an example of a heterologous envelope glycoprotein to be incorporated. We also describe how these particles are used to infect susceptible cells and to perform a quantitative infectivity readout by a luciferase assay.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 059998086

Download citation: RISBibTeXText

PMID: 28018942

Related references

Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. Journal of Clinical Virology 45(1): 54-60, 2009

Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins. Methods in Molecular Biology 454: 331-338, 2008

Differences in the internalization of self-inactivating VSVG-pseudotyped murine leukemia virus-based vectors in human and murine cells. Journal of Virological Methods 255: 14-22, 2018

Pseudotyped vesicular stomatitis virus for functional analysis of SARS coronavirus spike protein. Advances in Experimental Medicine and Biology 581: 293-296, 2006

Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. Journal of General Virology 86(Pt 8): 2269-2274, 2005

Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59. Virology 174(1): 87-94, 1990

Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 273(1): 16-20, 2000

Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Human Gene Therapy 6(9): 1203-1213, 1995

Characterization of murine T-lymphoma and myeloid leukemia models based on infection with wildtype and Runx site mutant SL3-3 murine leukemia virus. Blood 102(11): 887a, 2003

A Moloney murine leukemia virus-based retroviral vector pseudotyped by the insect retroviral gypsy envelope can infect Drosophila cells. Journal of Virology 72(1): 853-856, 1998

Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein. Human Gene Therapy 21(12): 1665-1673, 2010

Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses. Journal of Virology 72(6): 5313-5317, 1998

Marrow macrophages are a primary target for infection and transformation by murine sarcoma viruses and show altered production of humoral mediators of hemopoiesis following infection with murine leukemia virus. Journal Of Supramolecular Structurepl. 3: 298, 1979

Amplified expression of murine leukemia virus coded antigens on thymocytes and leukemia cells of akr mice after infection by dualtropic mink cell focus forming murine leukemia virus. Virology 119(2): 450-464, 1982

Pseudotyped murine leukemia virus for schistosome transgenesis: approaches, methods and perspectives. Transgenic Research 23(3): 539-556, 2014